País: Austrália
Língua: inglês
Origem: Department of Health (Therapeutic Goods Administration)
oxymetazoline hydrochloride, Quantity: 0.5 mg/mL
Bayer Australia Ltd
oxymetazoline hydrochloride
Spray, nasal
Excipient Ingredients: sodium hydroxide; hydrochloric acid; propylene glycol; monobasic sodium phosphate monohydrate; disodium edetate; purified water; benzalkonium chloride
Nasal
15mL, 30 mL
(S2) Pharmacy Medicine
Indicated for symptomatic relief of nasal and nasopharyngeal congestion associated with the common cold, hayfever and sinusitis, and to facilitate visual intranasal examination. By decreasing congestion around the eustachian tube ostia, Drixine Nasal may be useful in the adjunctive treatment of congestion associated with middle ear conditions.
Visual Identification: Clear colourless soluton; Container Type: Bottle; Container Material: LDPE; Container Life Time: 21 Months; Container Temperature: Store below 30 degrees Celsius
Registered
2009-05-06